ALNY vs GOVX · P/E 76, rev $1.29B vs $10.6M cap
Alnylam Pharmaceuticals Inc (ALNY) versus GeoVax Labs Inc (GOVX) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
GeoVax Labs Inc (GOVX) is a biotechnology company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported GOVX revenue for 2026-06-30 was $0. Net income was -$9.7M. GOVX currently screens at market cap $10.6M.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. GOVX currently screens at market cap $10.6M.
Not investment advice. Open the ALNY and GOVX stock pages for the full models.
Not investment advice.